Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Unipro reported for 6 months of 2024 by RAS

7/26/24 UPRO

L5-Energo increased its output by 10.3%

7/26/24 ELFV

Moscow Exchange to add 15 more OTC shares

7/26/24 MOEX

Stavropolenergosbyt reported for 6 months of 2024 by RAS

7/26/24 STSB

Permenergosbyt reported for 6 months of 2024 by RAS

7/26/24 PMSB

KuibyshevAzot reported for 6 months of 2024 by RAS

7/26/24 KAZT

Rosseti Volga reported for 6 months of 2024 by RAS

7/26/24 MRKV

Mordovenergosbyt reported for 6 months of 2024 by RAS

7/26/24 MRSB

Yuzhuralzoloto has completed construction of a factory at Vysokoye

7/26/24 UGLD

Samolet reported for 6 months of 2024 by RAS

7/26/24 SMLT